about
The role of functional dopamine-transporter SPECT imaging in parkinsonian syndromes, part 2Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trialB Cell lymphoma of the brain stem masquerading as myastheniaObese patients after gastric bypass surgery have lower brain-hedonic responses to food than after gastric banding.Whole Brain Magnetic Resonance Image Atlases: A Systematic Review of Existing Atlases and Caveats for Use in Population Imaging.Visual and proprioceptive interaction in patients with bilateral vestibular loss.Ghrelin mimics fasting to enhance human hedonic, orbitofrontal cortex, and hippocampal responses to food.Functional imaging in adult and paediatric brain tumours.The role of functional dopamine-transporter SPECT imaging in parkinsonian syndromes, part 1.1H-MRS evaluation of metabolism in Alzheimer's disease and vascular dementia.A practical review of the neuropathology and neuroimaging of multiple sclerosis.Structural neuroimaging in preclinical dementia: From microstructural deficits and grey matter atrophy to macroscale connectomic changes.Posterior reversible encephalopathy syndrome: a possible late interaction between cytotoxic agents and general anaesthesia.A simple procedure to improve FMRIb Software Library Brain Extraction Tool performance.Quantitative imaging biomarkers in neuro-oncology.In vivo imaging of cerebral dopamine D3 receptors in alcoholism.Age independently affects myelin integrity as detected by magnetization transfer magnetic resonance imaging in multiple sclerosis.Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas.Short echo time proton magnetic resonance spectroscopy in Alzheimer's disease: a longitudinal multiple time point studyEndogenous opioid release in the human brain reward system induced by acute amphetamine administration.Increased PK11195-PET binding in normal-appearing white matter in clinically isolated syndromeHematopoietic mobilization: Potential biomarker of response to natalizumab in multiple sclerosis.Lapatinib access into normal brain and brain metastases in patients with Her-2 overexpressing breast cancer.Increased PK11195 PET binding in the cortex of patients with MS correlates with disabilityFunctional neuroimaging findings in healthy middle-aged adults at risk of Alzheimer's disease.Management of incidental findings during imaging research in "healthy" volunteers: current UK practiceThree different brain tumours evolving from a common originTreatment-Resistant Schizophrenia Patients Show Elevated Anterior Cingulate Cortex Glutamate Compared to Treatment-Responsive.Blunted Endogenous Opioid Release Following an Oral Amphetamine Challenge in Pathological GamblersEarly primary biliary cholangitis is characterised by brain abnormalities on cerebral magnetic resonance imaging.Analysis of ageing-associated grey matter volume in patients with multiple sclerosis shows excess atrophy in subcortical regions.A longitudinal study of patients with cirrhosis treated with L-ornithine L-aspartate, examined with magnetization transfer, diffusion-weighted imaging and magnetic resonance spectroscopy.The ICCAM platform study: An experimental medicine platform for evaluating new drugs for relapse prevention in addiction. Part B: fMRI description.Disconnection between the default mode network and medial temporal lobes in post-traumatic amnesia.Flutriciclamide (18F-GE180) PET: First-in-Human PET Study of Novel Third-Generation In Vivo Marker of Human Translocator Protein.An MRS- and PET-guided biopsy tool for intraoperative neuronavigational systems.The Imperial College Cambridge Manchester (ICCAM) platform study: An experimental medicine platform for evaluating new drugs for relapse prevention in addiction. Part A: Study description.Decreased hippocampal translocator protein (18 kDa) expression in alcohol dependence: a [11C]PBR28 PET studySubacute pulmonary granulomatous schistosomiasis: high resolution CT appearances--another cause of the halo sign.Advances in pituitary imaging technology and future prospects.
P50
Q27011665-10A4514F-6DF2-404F-BCC6-7137A8EC5FBDQ28286628-981DC25B-EE1A-4218-A777-70C490193C43Q28345232-B402BAA3-788E-46D0-9FA8-6F9CB3E66680Q28659292-3CABEFAB-2C39-46D8-A1D8-A4C64D92109BQ30238623-682BC22B-6CC8-4D88-ADB8-754AB1A3B06AQ30434330-BB55591E-2608-48A8-B8D6-3D76FB9CCE6EQ30457922-DFB60363-A005-4BE0-AAFF-CD3C7801725FQ30577397-059D1F2E-FF1B-4E22-BCF1-1FBF886E315CQ30829363-6E784E28-C94C-4F64-9859-632D245AC302Q30945792-4C5FFBDE-B298-4185-BB1F-8F02422BB47FQ31062386-53C43933-D1BF-4BB8-8147-8171FC127F11Q31138795-E49FC221-2D35-4143-9B6E-DABD5AFD03C7Q33218296-ECD38E5A-B66B-4EBF-AA46-2B12CF2AA5CDQ33313562-420F7EB7-7A12-4946-B21A-DAA27BFAD8A9Q33472027-DB2D0EC9-5425-4750-9618-FF92BBB00A06Q33620597-93B745BA-423E-4862-9490-84F1F8F8D094Q33741396-2528E195-5BF8-4A9D-9BFA-14DCE4F4DF02Q33865523-B0A2DFBC-F6B4-4CBB-9958-900200082312Q34247831-7FF7D576-EAA5-443C-8680-B38BE642E1BFQ34258315-009F014D-4D79-46A4-85DA-6B5C5978AE94Q35248914-A6B01DE0-9AB4-4419-BE6E-279CC4C50E7FQ35400555-D84C0F6D-F58E-463C-8BB4-7D3A64268384Q35582767-659A16B3-DDF7-411A-A998-97D9862F5D0AQ36146941-CBC365B3-303C-48E4-9864-4F23B2C1983BQ36323118-7A383746-5211-4025-89E1-F2003DED10CCQ36325490-7E69F20E-FACB-49BD-A74C-F2620AA75906Q36809583-DA2B6036-8AF3-4687-A82F-7B66DF46C89BQ36817154-4B0A39FF-C3E6-4CF3-8EB0-14E085F89671Q36906636-ACE6D65C-57EB-4B17-8501-3E9554850F7CQ37371069-AE048565-B790-4763-83B2-D1CDD1CDAB03Q37433538-AA1AF4AD-5579-45F1-B9A8-30A227595F92Q37578424-304D30AD-ADF9-4537-93BA-39BF3BC9FD50Q37722642-160B4A31-03FF-4389-A706-7EC3949DED87Q37739870-5417B0AD-561F-4795-B2F8-F73DF82F9C53Q38801143-C8F58BB8-13A0-465A-89CF-C75FE9D37A2EQ38901179-A7FE8B26-7E34-4B8D-BB2D-5DE3F518D5B8Q38977208-B75939F1-909F-4049-9859-11C298F574CBQ39029440-59CD0BD1-C29C-4904-89B9-C000B6EBF0C8Q39568751-6456885B-46D4-404F-A9D6-DA57290AD98FQ39656589-2E6843B6-0CA2-4D15-ADFB-E34D52A5D98A
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Adam D Waldman
@ast
Adam D Waldman
@en
Adam D Waldman
@es
Adam D Waldman
@nl
Adam D Waldman
@sl
type
label
Adam D Waldman
@ast
Adam D Waldman
@en
Adam D Waldman
@es
Adam D Waldman
@nl
Adam D Waldman
@sl
prefLabel
Adam D Waldman
@ast
Adam D Waldman
@en
Adam D Waldman
@es
Adam D Waldman
@nl
Adam D Waldman
@sl
P106
P21
P31
P496
0000-0003-4398-6431